Longevity
California Firefighters Will Use Biomarker Testing To Prevent Job-Related Health Risks
Longevity platform Hundred Health will provide personalized biomarker insights and 100-day plans to help California firefighters monitor risks.
Having a Younger Biological Age Is Linked to Better Brain Health
A preliminary study found that having a lower biological age compared to chronological age is associated with decreased risk of stroke and better cognitive performance.
Stanford’s First Consumer Health Conference Tackles Longevity, Wearables & the Future of Preventive Care
Stanford’s sold-out event mapped the science and business models required to move preventive health beyond its early-adopter phase and into mass adoption.
Doctors Are Deeply Divided When It Comes to Longevity Protocols
A new survey reveals which supplements, medicines and lifestyle interventions doctors personally use — from vitamin D to routines costing over $1,000 per month.
UFC Gym Adds In-Club Longevity Clinics Featuring GLP-1s, Peptides
UFC GYM and NexGen MD Scientific are launching in-club longevity clinics, giving members access to GLP-1s and peptides.
Lindora Eyes Revamped Franchise Growth Under New Owners Next Health
Next Health bought Lindora from Xponential Fitness. Now it's rebuilding the brand and franchisees are already lining up.
In a Longevity-Obsessed World, ‘Well-Being Status’ Is the New Flex
Health metrics such as sleep scores and VO2 max are now status symbols. A neuroscientist says the obsession runs deeper than wellness — and so do the risks.
Amazon Enters Lab-Testing Race Through Lifeforce Partnership
Amazon just became the next major player to enter the biomarker blood testing wars with the launch of Health Insights.
ATN Week in Review: What’s Next for the Longevity Movement?
This week, we break down the recent controversy surrounding Peter Attia's ties to Jeffrey Epstein, and what it could mean for the future of longevity science.
Function Sues Rival Lab-Testing Startup Superpower, Alleging False Marketing
Function Health alleges Superpower made misleading claims around biomarker testing and clinical support, and in social media advertising.
